Investigates fluorescence and anticancer effects of diphenylamino-thiazole chromophores in cancer cell lines, suggesting potential for drug development.
Three diphenylamino-thiazole donor-π-acceptor Schiff-base chromophores 5a-5c were designed and synthesized to explore their photophysical properties and anticancer potential. The synthesized structures were characterized by FTIR and 1H/13C NMR, and mass spectrometry. UV-Vis studies revealed pronounced positive solvatochromism (λmax = 406–470 nm), consistent with efficient intramolecular charge transfer, and supported by density functional theory calculations. The chromophores exhibited strong visible emission (529–594 nm) with large Stokes shifts (≈ 4.3–5.6 × 103 cm− 1), indicating important excited-state relaxation. Kamlet-Taft analysis identified solvent dipolarity/polarizability and hydrogen-bond acceptor ability as dominant factors governing solvatochromism (R2 = 0.977–0.983). Time-dependent density functional theory calculations reproduced the experimental spectra, confirming HOMO→LUMO π→π* Intramolecular Charge Transfer transitions and effective donor-acceptor electronic communication. Cytotoxic evaluation revealed against HT-29, MCF-7, and HepG2 cell lines, with chromophore 5b showing the highest potency (IC50 = 11.30 ± 0.61–16.46 ± 0.37 µM), comparable to Sorafenib, while maintaining low toxicity toward WI-38 normal cells, indicating acceptable selectivity. Molecular docking revealed moderate binding affinities, particularly for chromophore 5a (S = -7.05 kcal/mol), surpassing the reference drug and suggesting a preliminary inhibitory scaffold. Moreover, in silico pharmacokinetic analysis indicated acceptable drug-likeness, with satisfactory molecular weight, lipophilicity (LogP ≈ 4.0-4.7), TPSA (50.9–96.8 Å2), and good predicted oral bioavailability. Overall, these in vitro findings identify diphenylamino-thiazole chromophores, particularly 5b and 5a, as promising candidates for further development as preclinical investigation with integrated optoelectronic functionality.
No takes yet. Share an insight, caveat, or question.
Alshahrani et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: